{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:57:31Z","timestamp":1786993051326,"version":"build-2736575974"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1018\/13"],"award-info":[{"award-number":["1018\/13"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.joca.2017.10.013","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T22:31:21Z","timestamp":1508797881000},"page":"7-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Hierarchical, imbalanced pro-inflammatory cytokine networks govern the pathogenesis of chronic arthropathies"],"prefix":"10.1016","volume":"26","author":[{"given":"G.","family":"Livshits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kalinkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2017.10.013_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nrrheum.2015.92","article-title":"Epidemiology research in rheumatology \u2013 progress and pitfalls","volume":"11","author":"Symmons","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.joca.2012.11.012","article-title":"Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)","volume":"21","author":"Berenbaum","year":"2013","journal-title":"Osteoarthr Cartil"},{"key":"10.1016\/j.joca.2017.10.013_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrrheum.2013.160","article-title":"Role of cytokines in intervertebral disc degeneration: pain and disc content","volume":"10","author":"Risbud","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nm.3260","article-title":"How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy","volume":"19","author":"Schett","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.joca.2017.10.013_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00281-017-0619-z","article-title":"Selected cytokine pathways in rheumatoid arthritis","volume":"39","author":"Noack","year":"2017","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.joca.2017.10.013_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1600-065X.1995.tb00070.x","article-title":"Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease","volume":"144","author":"Maini","year":"1995","journal-title":"Immunol Rev"},{"key":"10.1016\/j.joca.2017.10.013_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrrheum.2015.171","article-title":"Cytokines in rheumatoid arthritis \u2013 shaping the immunological landscape","volume":"12","author":"McInnes","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-3-540-31339-7_4","article-title":"The theory of biological robustness and its implication in cancer","volume":"61","author":"Kitano","year":"2007","journal-title":"Ernst Schering Res Found Workshop"},{"key":"10.1016\/j.joca.2017.10.013_bib9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cyto.2015.08.260","article-title":"The role of cytokines in the pathogenesis of rheumatoid arthritis \u2013 practical and potential application of cytokines as biomarkers and targets of personalized therapy","volume":"76","author":"Brzustewicz","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.joca.2017.10.013_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/jir.2011.0050","article-title":"Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis","volume":"31","author":"Volin","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.joca.2017.10.013_bib11","first-page":"73","article-title":"Clinical significance of interleukin-32 expression in patients with rheumatoid arthritis","volume":"31","author":"Gui","year":"2013","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.joca.2017.10.013_bib12","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/imm.12660","article-title":"Functions of interleukin-34 and its emerging association with rheumatoid arthritis","volume":"149","author":"Zhou","year":"2016","journal-title":"Immunology"},{"key":"10.1016\/j.joca.2017.10.013_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12891-015-0516-3","article-title":"Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from rheumatoid arthritis patients","volume":"16","author":"Santos Savio","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.joca.2017.10.013_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10067-005-0106-0","article-title":"Clinical significance of IL-18, IL-15, IL-12 and TNF-alpha measurement in rheumatoid arthritis","volume":"25","author":"Petrovic-Rackov","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.semarthrit.2017.03.008","article-title":"Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"42","author":"Cantini","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.semarthrit.2016.09.003","article-title":"Defining the optimal biological monotherapy in rheumatoid arthritis: a systematic review and meta-analysis of randomised trials","volume":"46","author":"Tarp","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib17","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1186\/ar2772","article-title":"Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies","volume":"11","author":"Moran","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib18","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1016\/j.ajpath.2015.07.017","article-title":"Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis","volume":"185","author":"Kim","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joca.2017.10.013_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-med-051914-021944","article-title":"Therapeutic targeting of IL-17 and IL-23 cytokines in immune-mediated diseases","volume":"67","author":"Fragoulis","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.joca.2017.10.013_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cei.12449","article-title":"Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation","volume":"179","author":"Scrivo","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.joca.2017.10.013_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cyto.2007.10.004","article-title":"The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy","volume":"41","author":"Kragstrup","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.joca.2017.10.013_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.drudis.2015.08.002","article-title":"IL-20 in rheumatoid arthritis","volume":"22","author":"Hsu","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.joca.2017.10.013_bib23","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.33446","article-title":"Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib24","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/art.39083","article-title":"Efficacy and safety of anti-interleukin-20 monoclonal antibody in patients with rheumatoid arthritis: a randomized phase IIa trial","volume":"67","author":"\u0160enolt","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib25","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/jidsymp.2013.8","article-title":"The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders","volume":"16","author":"Waldmann","year":"2013","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.joca.2017.10.013_bib26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.21731","article-title":"Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin-15 on the cell surface and promote osteoclastogenesis in autologous monocytes","volume":"54","author":"Miranda-Car\u00fas","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib27","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3904\/kjim.2016.098","article-title":"Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis","volume":"231","author":"Kim","year":"2016","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.joca.2017.10.013_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrd.2016.231","article-title":"Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases","volume":"16","author":"Hamilton","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.joca.2017.10.013_bib29","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/rheumatology\/kev252","article-title":"Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2017.10.013_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cyto.2015.12.020","article-title":"IL-9, a local growth factor for synovial T cells in inflammatory arthritis","volume":"79","author":"Kundu-Raychaudhuri","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.joca.2017.10.013_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13075-016-0973-6","article-title":"Colony-stimulating factor (CSF) 1 receptor blockade reduces inflammation in human and murine models of rheumatoid arthritis","volume":"18","author":"Garcia","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib32","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1007\/s00198-014-2808-0","article-title":"Osteocyte control of bone remodeling: is sclerostin a key molecular coordinator of the balanced bone resorption-formation cycles?","volume":"25","author":"Sapir-Koren","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.joca.2017.10.013_bib33","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.cellsig.2013.04.002","article-title":"Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling","volume":"25","author":"Miao","year":"2013","journal-title":"Cell Signal"},{"key":"10.1016\/j.joca.2017.10.013_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8515-6","article-title":"Bone as a target organ in rheumatic disease: impact on impact on osteoclasts and osteoblasts","volume":"51","author":"Baum","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.joca.2017.10.013_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.joca.2017.10.013_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/14712598.2017.1263614","article-title":"Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis","volume":"17","author":"Chiu","year":"2017","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib37","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1136\/ard.2008.097048","article-title":"Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure","volume":"68","author":"M\u00f8ller D\u00f8hn","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.10.013_bib38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.joca.2017.10.013_bib39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1128\/CVI.00061-11","article-title":"Distinct effects of anti-tumor necrosis factor combined therapy on TH1\/TH2 balance in rheumatoid arthritis patients","volume":"18","author":"Herman","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.joca.2017.10.013_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/art.38896","article-title":"Combined inhibition of tumor necrosis factor \u03b1 and interleukin-17 as a therapeutic opportunity in rheumatoid arthritis: development and characterization of a novel bispecific antibody","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s13075-016-1197-5","article-title":"Increase in circulating Th17 cells during anti-TNF therapy is associated with ultrasonographic improvement of synovitis in rheumatoid arthritis","volume":"18","author":"Hull","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib42","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/art.30418","article-title":"Tumor necrosis factor-interleukin-17 interplay induces S100A8, interleukin-1\u03b2, and matrix metalloproteinases, and drives irreversible cartilage destruction in murine arthritis: rationale for combination treatment during arthritis","volume":"63","author":"Koenders","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2174\/1389201015666140113111711","article-title":"Construction of an anti-IL-1\u03b2 scfv and TNFRI fusion protein and its therapeutic effect on RA mice model","volume":"14","author":"Kan","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.joca.2017.10.013_bib44","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/art.27689","article-title":"Interleukin-20 antibody is a potential therapeutic agent for experimental arthritis","volume":"62","author":"Hsu","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib45","doi-asserted-by":"crossref","first-page":"e0171757","DOI":"10.1371\/journal.pone.0171757","article-title":"Higher efficacy of anti-IL-6\/IL-21 combination therapy compared to monotherapy in the induction phase of Th17-driven experimental arthritis","volume":"12","author":"Roeleveld","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2017.10.013_bib46","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment","volume":"65","author":"van Kuijk","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"Suppl","key":"10.1016\/j.joca.2017.10.013_bib47","first-page":"73","article-title":"The role of tumor necrosis factor-\u03b1 blockers in psoriatic disease. Therapeutic options in psoriatic arthritis","volume":"93","author":"Addimanda","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/1744666X.2016.1218761","article-title":"An update on the use of tumor necrosis factor alpha inhibitors in the treatment of ankylosing spondylitis","volume":"13","author":"Osman","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.joca.2017.10.013_bib49","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10067-016-3263-4","article-title":"IL-23\/IL-17 axis in spondyloarthritis -bench to bedside","volume":"35","author":"Raychaudhuri","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib50","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1517\/14728214.2016.1146679","article-title":"Emerging drugs for psoriatic arthritis","volume":"21","author":"Caso","year":"2016","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.joca.2017.10.013_bib51","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar3781","article-title":"Functional role of IL-22 in psoriatic arthritis","volume":"14","author":"Mitra","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib52","doi-asserted-by":"crossref","first-page":"e000284","DOI":"10.1136\/rmdopen-2016-000284","article-title":"Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice","volume":"3","author":"Miossec","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.joca.2017.10.013_bib53","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"issue":"Suppl 2","key":"10.1016\/j.joca.2017.10.013_bib54","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/rheumatology\/kew345","article-title":"Differential mechanisms of de-regulated bone formation in rheumatoid arthritis and spondyloarthritis","volume":"55","author":"Goldring","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.joca.2017.10.013_bib55","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.39649","article-title":"Interleukin-9 overexpression and Th9 polarization characterize the inflamed gut, the synovial tissue, and the peripheral blood of patients with psoriatic arthritis","volume":"68","author":"Ciccia","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib56","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13075-015-0870-4","article-title":"High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation","volume":"17","author":"Li","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000471798","article-title":"New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions","volume":"233","author":"Li","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.joca.2017.10.013_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s40265-017-0709-1","article-title":"Apremilast: a review in psoriasis and psoriatic arthritis","volume":"77","author":"Keating","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.joca.2017.10.013_bib59","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.39120","article-title":"Apremilast in patients with active rheumatoid arthritis: a phase ii, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"67","author":"Genovese","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib60","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/art.34453","article-title":"Osteoarthritis: a disease of the joint as an organ","volume":"64","author":"Loeser","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BOR.0000000000000162","article-title":"Biologic basis of osteoarthritis: state of the evidence","volume":"27","author":"Malemud","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib62","doi-asserted-by":"crossref","first-page":"561459","DOI":"10.1155\/2014\/561459","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis","volume":"2014","author":"Wojdasiewicz","year":"2014","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.joca.2017.10.013_bib63","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib65","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10067-013-2171-0","article-title":"Aggrecanases in the human synovial fluid at different stages of osteoarthritis","volume":"32","author":"Zhang","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.joca.2017.10.013_bib66","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.joca.2014.12.007","article-title":"Differential expression of interleukin-17 and interleukin-22 in inflamed and non-inflamed synovium from osteoarthritis patients","volume":"23","author":"Deligne","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.10.013_bib67","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1080\/14712598.2016.1229774","article-title":"Monoclonal antibodies for the treatment of osteoarthritis","volume":"16","author":"Zheng","year":"2016","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.13000","article-title":"Systemic neutralization of TGF-\u03b2 attenuates osteoarthritis","volume":"1376","author":"Xie","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.joca.2017.10.013_bib69","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00296-015-3251-z","article-title":"TGF-\u03b2 signal transduction pathways and osteoarthritis","volume":"35","author":"Zhai","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.joca.2017.10.013_bib70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/157339710793205684","article-title":"Outlines of the biochemistry of osteoarthritis","volume":"6","author":"Livshits","year":"2010","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.joca.2017.10.013_bib71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cytogfr.2011.04.003","article-title":"Crosstalk between cartilage and bone: when bone cytokines matter","volume":"22","author":"Funck-Brentano","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.joca.2017.10.013_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/1440-1681.12567","article-title":"Circulating T helper 9 cells and increased serum interleukin-9 levels in patients with knee osteoarthritis","volume":"43","author":"Qi","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.joca.2017.10.013_bib73","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1186\/ar4037","article-title":"Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development","volume":"14","author":"Cook","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib74","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11926-012-0305-z","article-title":"Low back pain and lumbar spine osteoarthritis: how are they related?","volume":"15","author":"Goode","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.joca.2017.10.013_bib75","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1136\/ard.2010.137836","article-title":"Lumbar disc degeneration and genetic factors are the main risk factors for low back pain in women: the UK Twin Spine Study","volume":"70","author":"Livshits","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.10.013_bib76","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semcdb.2016.05.008","article-title":"Decoding the intervertebral disc: unravelling the complexities of cell phenotypes and pathways associated with degeneration and mechanotransduction","volume":"62","author":"Kerr","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.joca.2017.10.013_bib77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dna.2016.3230","article-title":"The paracrine effect of degenerated disc cells on healthy human nucleus pulposus cells is mediated by MAPK and NF-\u03baB pathways and can be reduced by TGF-\u03b21","volume":"36","author":"Cai","year":"2017","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.joca.2017.10.013_bib78","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1615\/CritRevEukaryotGeneExpr.2015012369","article-title":"Symptomatic versus asymptomatic intervertebral disc degeneration: is inflammation the key?","volume":"25","author":"Peng","year":"2015","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.joca.2017.10.013_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/abbs\/gmw112","article-title":"Tumor necrosis factor-\u03b1: a key contributor to intervertebral disc degeneration","volume":"49","author":"Wang","year":"2017","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.joca.2017.10.013_bib80","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/jor.22959","article-title":"Response to tumor necrosis factor-\u03b1 mediated inflammation involving activation of prostaglandin E2 and Wnt signaling in nucleus pulposus cells","volume":"33","author":"Hiyama","year":"2015","journal-title":"J Orthop Res"},{"key":"10.1016\/j.joca.2017.10.013_bib81","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.joca.2015.02.017","article-title":"Potential roles of cytokines and chemokines in human intervertebral disc degeneration: interleukin-1 is a master regulator of catabolic processes","volume":"23","author":"Phillips","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2017.10.013_bib82","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jbiomech.2016.02.029","article-title":"Do mechanical strain and TNF-\u03b1 interact to amplify pro-inflammatory cytokine production in human annulus fibrosus cells?","volume":"49","author":"Likhitpanichkul","year":"2016","journal-title":"J Biomech"},{"key":"10.1016\/j.joca.2017.10.013_bib83","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijsu.2017.06.024","article-title":"Cytokine and chemokine profile changes in patients with lower segment lumbar degenerative spondylolisthesis","volume":"43","author":"Sutovsky","year":"2017","journal-title":"Int J Surg"},{"key":"10.1016\/j.joca.2017.10.013_bib84","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/BRS.0000000000001621","article-title":"Interleukin-9 promotes TNF-\u03b1 and PGE2 release in human degenerated intervertebral disc tissues","volume":"41","author":"Zhang","year":"2016","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.joca.2017.10.013_bib85","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s10753-016-0435-y","article-title":"Salubrinal suppresses IL-17-induced upregulation of MMP-13 and extracellular matrix degradation through the NF-kB pathway in human nucleus pulposus cells","volume":"39","author":"Yao","year":"2016","journal-title":"Inflammation"},{"key":"10.1016\/j.joca.2017.10.013_bib86","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13018-016-0343-8","article-title":"Interleukin-23 may contribute to the pathogenesis of lumbar disc herniation through the IL-23\/IL-17 pathway","volume":"11","author":"Jiang","year":"2016","journal-title":"J Orthop Surg Res"},{"key":"10.1016\/j.joca.2017.10.013_bib87","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1302\/2046-3758.59.BJR-2016-0032.R1","article-title":"Bone morphogenetic protein-2 provokes interleukin-18-induced human intervertebral disc degeneration","volume":"5","author":"Ye","year":"2016","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.joca.2017.10.013_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13075-017-1332-y","article-title":"RANK\/RANKL\/OPG system in the intervertebral disc","volume":"19","author":"Takegami","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2017.10.013_bib89","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial disease in psoriatic arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.10.013_bib90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.rdc.2012.08.003","article-title":"Pathophysiology of new bone formation and ankylosis in spondyloarthritis","volume":"38","author":"Lories","year":"2012","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.joca.2017.10.013_bib92","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/art.24767","article-title":"Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis","volume":"60","author":"Schett","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.013_bib93","doi-asserted-by":"crossref","first-page":"2405291","DOI":"10.1155\/2017\/2405291","article-title":"Cytokine imbalance as a common mechanism in both psoriasis and rheumatoid arthritis","volume":"2017","author":"Tan","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.joca.2017.10.013_bib94","article-title":"Expanding diversity and common goal of regulatory T and B cells. I: origin, phenotype, mechanisms","author":"Bocian","year":"2017","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.joca.2017.10.013_bib95","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cyto.2014.10.031","article-title":"Interleukin-10 paradox: a potent immunoregulatory cytokine that has been difficult to harness for immunotherapy","volume":"74","author":"Saxena","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.joca.2017.10.013_bib96","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10753-016-0453-9","article-title":"Interleukin-35: a potential therapeutic agent for autoimmune diseases","volume":"40","author":"Guan","year":"2017","journal-title":"Inflammation"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417312748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417312748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:46:57Z","timestamp":1761018417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458417312748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1063458417312748"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2017.10.013","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hierarchical, imbalanced pro-inflammatory cytokine networks govern the pathogenesis of chronic arthropathies","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2017.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}